Merit Medical Systems Inc
NASDAQ:MMSI
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
4.4B USD |
Loading...
|
|
| JP |
|
Hoya Corp
TSE:7741
|
9T JPY |
Loading...
|
|
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
57.9B USD |
Loading...
|
|
| CH |
|
Alcon AG
SIX:ALC
|
30B CHF |
Loading...
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
102.1B DKK |
Loading...
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.4B USD |
Loading...
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.7B GBP |
Loading...
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
42.8B CNY |
Loading...
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6B USD |
Loading...
|
|
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
840B JPY |
Loading...
|
|
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
4.7B USD |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
Merit Medical Systems Inc
Glance View
Merit Medical Systems Inc. stands as a hallmark of innovation and precision in the medical device industry. Founded in 1987, this Utah-based company has carved a niche by developing and manufacturing a diverse range of products designed to enhance the ability of physicians and improve patient care. Merit's operations focus on the production of disposable medical devices catering primarily to the fields of interventional cardiology, radiology, endoscopy, and pain management. These products, which include a variety of catheters, microcatheters, embolization coils, and other technical components, are crucial in facilitating minimally invasive procedures that speak to the modern medical demand for efficiency and reduced patient recovery times. The company's relentless pursuit of quality and innovation has spurred consistent growth and expanded its presence globally, illustrating its commitment to meeting the evolving needs of healthcare providers and their patients. Revenue streams for Merit Medical Systems derive primarily from the sales of these specialized medical devices, accompanied by an expanding portfolio of customer-driven services and support. Unlike many companies that might get mired in a single product line, Merit has strategically diversified its offerings to spread risk and capture a broader segment of the healthcare market. This diversification is reflected in their investment in research and development, enabling the launch of new products regularly, thereby cushioning the company against the volatility typically seen in the medical device sector. The company’s success is a testament to its ability to maintain close relationships with healthcare providers, listening to and fulfilling their complex needs while operating through an intricate web of direct sales representatives and distribution partners globally. This cohesive model fosters both customer loyalty and drives sustainable business growth, ensuring that Merit Medical Systems remains a pivotal player in the evolving landscape of medical technology.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Merit Medical Systems Inc is 48.7%, which is above its 3-year median of 47.1%.
Over the last 3 years, Merit Medical Systems Inc’s Gross Margin has increased from 45.1% to 48.7%. During this period, it reached a low of 45.1% on Dec 31, 2022 and a high of 48.7% on Jan 1, 2026.